Absence of microglia promotes diverse pathologies and early lethality in Alzheimer’s disease mice is a research paper published in Cell Reports (2022). On theSindex it has a DataRank of 0. It has been cited 184 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: P30-AG066519
National Institutes of Health
Grant: R01-AG056303
National Institutes of Health
Grant: R01AG061895
National Institutes of Health
Grant: R61-HL154307
National Institutes of Health
Grant: RF1-AG055524
National Institutes of Health
Grant: RF1-DA048813
National Institute on Aging
Grant: T32-AG00096
National Institute on Aging
Grant: T32-AG073088
National Health and Medical Research Council
Grant: GNT1163981
CSF1R and the control of microglial function
National Institute of Neurological Disorders and Stroke
Grant: T32-NS082174
California Institute for Regenerative Medicine
Grant: EDUC4-12822
NIA NIH HHS
Grant: R01 AG056303
NIDA NIH HHS
Grant: RF1 DA048813
NIA NIH HHS
Grant: P30 AG066519
NHLBI NIH HHS
Grant: R61 HL154307
NINDS NIH HHS
Grant: T32 NS082174
NIA NIH HHS
Grant: RF1 AG055524
NIA NIH HHS
Grant: T32 AG000096
NIA NIH HHS
Grant: T32 AG073088
Medical Research Council
Grant: MR/M019969/1
National Institutes of Health
Grant: 5T32NS082174-05
Training Program in Stem Cell Translational Medicine for Neurological Disorders
National Institutes of Health
Grant: 3P30AG066519-01S1
The Alzheimer's Disease Research Center at the University of California, Irvine
National Institutes of Health
Grant: 1RF1DA048813-01
A novel platform for the investigation of human microglia
National Institutes of Health
Grant: 5T32AG073088-02
Training in Translational ADRD Neuroscience (TITAN)
National Institutes of Health
Grant: 5R01AG061895-03
Using human iPSC derived microglia and chimeric models to examine the role of PLCG2 in Alzheimers disease
National Institutes of Health
Grant: 1RF1AG055524-01A1
Examining the role of adaptive immunity in Alzheimer's Disease pathogenesis
National Institutes of Health
Grant: 1R61HL154307-01
A Vascularized Micro-Organ platform for the study of Brain-BBB-Blood interaction
National Institutes of Health
Grant: 5T32AG000096-12
TRAINING IN THE NEUROBIOLOGY OF AGING
National Institutes of Health
Grant: 5R01AG056303-03
Manipulating DNA repair enzymes to examine the interactions between aging and Alzheimers disease with iPSC-derived microglia
Medical Research Council
Cure Alzheimer's Fund
Mater Foundation
FWCI
12.59
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Additional file 1 of Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy
Additional file 1 of Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy
Additional file 2 of Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy
Additional file 2 of Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy
Additional file 3 of Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy
Additional file 3 of Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy
Additional file 4 of Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy
Additional file 4 of Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy
Additional file 5 of Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy
Additional file 5 of Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy
Additional file 6 of Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy
Additional file 6 of Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy
Additional file 2 of Cerebrospinal fluid shotgun proteomics identifies distinct proteomic patterns in cerebral amyloid angiopathy rodent models and human patients
Additional file 2 of Cerebrospinal fluid shotgun proteomics identifies distinct proteomic patterns in cerebral amyloid angiopathy rodent models and human patients
Additional file 1 of Alzheimer’s disease associated isoforms of human CD33 distinctively modulate microglial cell responses in 5XFAD mice
Additional file 1 of Alzheimer’s disease associated isoforms of human CD33 distinctively modulate microglial cell responses in 5XFAD mice
Additional file 1 of Cerebrospinal fluid shotgun proteomics identifies distinct proteomic patterns in cerebral amyloid angiopathy rodent models and human patients
Additional file 1 of Cerebrospinal fluid shotgun proteomics identifies distinct proteomic patterns in cerebral amyloid angiopathy rodent models and human patients
Additional file 4 of Alpha-synuclein inclusion responsive microglia are resistant to CSF1R inhibition
Additional file 5 of Alpha-synuclein inclusion responsive microglia are resistant to CSF1R inhibition